Quarterly report pursuant to Section 13 or 15(d)

Note 1 - Nature of Operations, Basis of Presentation and Consolidation (Details Textual)

v3.22.1
Note 1 - Nature of Operations, Basis of Presentation and Consolidation (Details Textual)
3 Months Ended
Mar. 31, 2022
shares
Restricted Stock [Member]  
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares) 169,690